DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Jubilant Pharmova Limited — Board Meeting Intimation

NSE 1 hr ago·7 Oct 2026, 2:17 pm

Jubilant Pharmova

Jubilant Pharmova Limited has announced that its board will meet on October 12, 2026, to discuss and consider a proposal for fund raising. This is a standard corporate procedure where the company reviews its capital requirements and evaluates various options to secure necessary financing.

For investors, this news is a neutral update indicating that the company is actively managing its financial strategy. It suggests the management is looking to strengthen its balance sheet or fund future growth initiatives, though the specific details of the fund raising remain undisclosed at this time.

Investors should watch for the official announcement following the meeting. The company will likely disclose the amount of funds being raised, the method of financing, and the intended use of the proceeds. This information will clarify the impact on the company's financial health and its future growth plans.